93 related articles for article (PubMed ID: 15235200)
21. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
[TBL] [Abstract][Full Text] [Related]
22. Pattern of perfusion defects seen in ischemic heart disease patients on technetium (Tc99m) tetrofosmin scanning.
Rahman A; Aftab J; Majeed R; Jaleel A; Basir F; Shah S; Khan RA
J Ayub Med Coll Abbottabad; 2005; 17(3):51-3. PubMed ID: 16320798
[TBL] [Abstract][Full Text] [Related]
23. 99Tcm tetrofosmin uptake in mediastinal tumours.
Ishibashi M; Fujimoto K; Ohzono H; Meno S; Hayabuchi N
Br J Radiol; 1996 Dec; 69(828):1134-8. PubMed ID: 9135469
[TBL] [Abstract][Full Text] [Related]
24. The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor.
Alexiou GA; Fotopoulos AD; Tsiouris S; Voulgaris S; Kyritsis AP
J Neurooncol; 2011 Sep; 104(2):611. PubMed ID: 21188468
[No Abstract] [Full Text] [Related]
25. [Relationship between lung-to-heart uptake ratio of technetium-99m-tetrofosmin during exercise myocardial single photon emission computed tomographic imaging and the number of diseased coronary arteries in patients with effort angina pectoris without myocardial infarction].
Okajima T; Ueshima K; Nishiyama O; Ogawa M; Ohuchi M; Saitoh M; Hiramori K
J Cardiol; 2004 Apr; 43(4):165-71. PubMed ID: 15125380
[TBL] [Abstract][Full Text] [Related]
26. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-tetrofosmin uptake in malignant lung tumours.
Başoğlu T; Sahin M; Coşkun C; Koparan A; Bernay I; Erkan L
Eur J Nucl Med; 1995 Jul; 22(7):687-9. PubMed ID: 7498232
[TBL] [Abstract][Full Text] [Related]
29. [Improved detection of fill-in using sublingual nitroglycerin in technetium-99m tetrofosmin exercise/rest single photon emission computed tomography one day protocol for old myocardial infarction].
Miyanaga H; Kunieda Y; Oguni A; Kamitani T; Kawasaki S; Takahashi T
J Cardiol; 1999 Mar; 33(3):135-43. PubMed ID: 10225193
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
31. Visualization of lung cancer with 99Tcm-tetrofosmin imaging: a comparison with 201T1.
Takekawa H; Tokaoka K; Tsukamoto E; Kanegae K; Kozeki Y; Yamaya A; Miller F; Kawakami Y
Nucl Med Commun; 1997 Apr; 18(4):341-5. PubMed ID: 9170619
[TBL] [Abstract][Full Text] [Related]
32. [Myocardial perfusion tomography imaging in patients without prior myocardial infarction--comparison between 201Tl, 99mTc-tetrofosmin and dual-isotope protocol (rest 201Tl/stress 99mTc-tetrofosmin)].
Kamínek M; Myslivecek M; Skvarilová M; Husák V; Lang O
Vnitr Lek; 1999 Feb; 45(2):81-4. PubMed ID: 15641225
[TBL] [Abstract][Full Text] [Related]
33. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
[TBL] [Abstract][Full Text] [Related]
35. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
[TBL] [Abstract][Full Text] [Related]
36. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
Hambÿe AS; Delsarte P; Vervaet AM
Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-tetrofosmin SPECT imaging of lung masses: a negative study.
Kao CH; ChangLai SP; Shen YY; Lee JK; Wang SJ
J Nucl Med; 1997 Jul; 38(7):1015-9. PubMed ID: 9225781
[TBL] [Abstract][Full Text] [Related]
38. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
[TBL] [Abstract][Full Text] [Related]
39. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.
He ZX; Iskandrian AS; Gupta NC; Verani MS
J Nucl Med; 1997 Jan; 38(1):44-8. PubMed ID: 8998148
[TBL] [Abstract][Full Text] [Related]
40. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
